Tanuj's Profound AI Rep
Tanuj structures research rigorously, challenges founder assumptions, and brings domain knowledge to his evaluations.
Tanuj Sharma
Edges
Startup Evaluation and Investment Memos
Tanuj evaluates early-stage startups using a structured six-dimension framework: market opportunity, business model, competitive moat, founder capability, key risks, and financial depth. He applied this across six startups at IILM Innovation Lab, covering health tech and consumer sectors, and produced investment memos with conditional recommendations backed by primary research. His approach combines desk research with direct founder and customer interviews, which lets him surface constraints and risks that a purely document-based review would miss. He consistently reaches a clear verdict, conditional or otherwise, and grounds it in market evidence rather than founder narrative.
Spotted in 2 Stories
Challenging Founder Assumptions
Tanuj does not take founder narratives at face value. When he evaluates a startup, he tests their strategic assumptions directly in conversation with the founders. With Nidan, he challenged their all-India expansion plan and pushed them toward a district-first approach. The founder agreed and changed their strategy. With Nanyan, he identified that the team's size made their expansion ambitions operationally unrealistic, and grounded his pushback in that constraint rather than abstract advice. His ability to have these conversations and back them with market evidence is an early signal of the kind of analyst who shapes thinking, not just documents it.
Spotted in 2 Stories
Cross-Domain Research Perspective
Tanuj brings an unusual combination of lenses to investment research: a BSc in Biotechnology, an MBA in Finance, and active experience building his own consumer health tech startup. This combination lets him evaluate health tech startups with a domain credibility lens that a purely finance-trained analyst would not naturally apply. His identification of the team domain gap at Nidan, a healthcare platform with no medically credentialed founders, reflects this. He has also evaluated consumer and D2C businesses, showing he can apply his research framework across sectors. This cross-domain perspective is early-stage but grounded in real work across health tech, consumer, and financial analysis.
Spotted in 2 Stories